FDA Enforcement Trends for Broadcast Advertisements

Posted 28 September 2017 By Justin Mann, Julie Tibbets

placeholder+image This article presents recent FDA enforcement trends related to broadcast advertisements and explains how regulatory professionals can approach the review and approval of promotional materials. The article also provides a review of relevant FDA authorities and guidance, as well as practical takeaways for industry with a focus on product ads appearing on TV or YouTube that may distract viewers from important risk information.

Share this article:

Categories: Drugs, Features, US, FDA, Advertising and Promotion

Tags: Office of Prescription Drug Promotion, OPDP, Warning Letter, YouTube, Social Media

Regulatory Exchange: Latest Updates From the Community